Low Dose Naltrexone (LDN) is gaining traction as an off-label treatment for fibromyalgia, with clinical studies showing 29% pain reduction and 65% of patients reporting benefits. We examine the mechanism, evidence, dosing protocols, and what patients actually experience.
A comprehensive review of the 2025 meta-analysis examining low dose naltrexone for fibromyalgia. Does LDN actually work for chronic pain? We break down 8 clinical trials, the TLR-4 mechanism, real effect sizes, and what patients should know before trying this off-label treatment.
Central sensitization is when your nervous system turns up the volume on pain signals—but it's reversible. This science-based guide explains what central sensitization really is, why it happens, and evidence-based treatments that can help rewire your pain system.